Search

everythinglearnresearchcommunity

for

Search:↓

Men generally face more severe COVID-19 outcomes than women, partly due to hormonal differences.

Certain genetic differences may affect how likely someone is to get COVID-19 and how severe it might be.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

COVID-19 temporarily affects male reproductive health, but sperm and testosterone levels generally return to normal after three months.

COVID-19 is caused by a virus from bats, and efforts focus on prevention and treatment research.

Organoids can help study COVID-19 and develop treatments, but face challenges like instability and limited renewal.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Migrants from certain regions had a higher risk of COVID-19 than Spaniards.

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

Cepharanthine and tetrandrine show promise as COVID-19 drugs.

Finasteride irreversibly affects human steroid 5α-reductase 2, providing insight into its catalytic mechanism and disease-related mutations.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

COVID-19 symptoms range from mild to severe, with older adults at higher risk.

Men, diabetes, and high inflammation levels lead to higher COVID-19 antibodies.

Natural products like flavonoids and phenolics may help treat or prevent COVID-19.

TMPRSS6 is crucial for controlling hepcidin and normal iron absorption.

5-Alpha-Reductase inhibitors shorten COVID-19 recovery time in men.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Spironolactone may help reduce COVID-19 severity in men by blocking harmful effects of certain hormones.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.

The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.

Use telemedicine and strict hygiene for safe hair and scalp treatments during COVID-19.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

Effective vaccines and treatments are crucial for long-term COVID-19 control.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Many COVID-19 patients have long-term symptoms, especially women, but certain medications may help reduce these symptoms.